Publication Archives - BioAegis Therapeutics https://www.bioaegistherapeutics.com/category/publication/ The Power of Innate Immunity Mon, 15 Dec 2025 16:36:54 +0000 en hourly 1 https://wordpress.org/?v=6.9.4 https://www.bioaegistherapeutics.com/wp-content/uploads/2020/02/cropped-BioAegis-Favicon500-32x32.webp Publication Archives - BioAegis Therapeutics https://www.bioaegistherapeutics.com/category/publication/ 32 32 Recombinant Human Plasma Gelsolin (rhu-pGSN) in a Patient Hospitalized with Critical COVID-19 Pneumonia https://pubmed.ncbi.nlm.nih.gov/34396087/#new_tab?utm_source=rss&utm_medium=rss&utm_campaign=recombinant-human-plasma-gelsolin-rhu-pgsn-in-a-patient-hospitalized-with-critical-covid-19-pneumonia Mon, 15 Dec 2025 16:28:36 +0000 https://www.bioaegistherapeutics.com/?p=5888 Catteeuw JV, DiNubile MJ. Clin Infect Pract. 2021 Nov;12:100088. doi: 10.1016/j.clinpr.2021.100088. Epub 2021 Aug 10. PMID: 34396087; PMCID: PMC8353968.

The post Recombinant Human Plasma Gelsolin (rhu-pGSN) in a Patient Hospitalized with Critical COVID-19 Pneumonia appeared first on BioAegis Therapeutics.

]]> Inflammatory Responses to Acute Carbon Monoxide Poisoning and the Role of Plasma Gelsolin. https://pubmed.ncbi.nlm.nih.gov/39919185/#new_tab?utm_source=rss&utm_medium=rss&utm_campaign=inflammatory-responses-to-acute-carbon-monoxide-poisoning-and-the-role-of-plasma-gelsolin Fri, 07 Feb 2025 16:22:00 +0000 https://www.bioaegistherapeutics.com/?p=5884 Arya AK, Sethuraman K, Waddell J, Cha YS, Liang Y, Bhopale VM, Bhat AR, Imtiyaz Z, Dakessian A, Lee Y, Thom SR. Science Advances. 2025 Feb 7;11(6):eado9751. doi: 10.1126/sciadv.ado9751. Epub 2025 Feb 7. PMID: 39919185; PMCID: PMC11804920.

The post Inflammatory Responses to Acute Carbon Monoxide Poisoning and the Role of Plasma Gelsolin. appeared first on BioAegis Therapeutics.

]]> Gelsolin Alleviates Rheumatoid Arthritis by Negatively Regulating NLRP3 Inflammasome Activation https://pubmed.ncbi.nlm.nih.gov/39179640/#new_tab?utm_source=rss&utm_medium=rss&utm_campaign=gelsolin-alleviates-rheumatoid-arthritis-by-negatively-regulating-nlrp3-inflammasome-activation Tue, 31 Dec 2024 16:25:00 +0000 https://www.bioaegistherapeutics.com/?p=5886 Lee J, Sasaki F, Koike E, Cho M, Lee Y, Dho SH, Lee J, Lee E, Toyohara E, Sunakawa M, Ishibashi M, Hung HH, Nishioka S, Komine R, Okura C, Shimizu M, Ikawa M, Yoshimura A, Morita R, Kim LK. Cell Death Differ. 2024 Dec;31(12):1679-1694. doi: 10.1038/s41418-024-01367-6. Epub 2024 Aug 24. PMID: 39179640; PMCID: PMC11618363.

The post Gelsolin Alleviates Rheumatoid Arthritis by Negatively Regulating NLRP3 Inflammasome Activation appeared first on BioAegis Therapeutics.

]]> Plasma Gelsolin Levels are Associated with Diabetes, Sex, Race, and Poverty https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04026-5#new_tab?utm_source=rss&utm_medium=rss&utm_campaign=plasma-gelsolin-levels-are-associated-with-diabetes-sex-race-and-poverty Fri, 10 Mar 2023 14:38:00 +0000 https://www.bioaegistherapeutics.com/?p=5815 Hooten, Nicole Noren, et al. Journal of Translational Medicine, 10 Mar 2023

The post Plasma Gelsolin Levels are Associated with Diabetes, Sex, Race, and Poverty appeared first on BioAegis Therapeutics.

]]> Proteomic Analysis Identifies Three Reliable Biomarkers of Intestinal Inflammation in the Stools of Patients With Inflammatory Bowel Disease https://doi.org/10.1093/ecco-jcc/jjac110#new_tab?utm_source=rss&utm_medium=rss&utm_campaign=proteomic-analysis-identifies-three-reliable-biomarkers-of-intestinal-inflammation-in-the-stools-of-patients-with-inflammatory-bowel-disease Fri, 27 Jan 2023 16:20:00 +0000 https://www.bioaegistherapeutics.com/?p=5882 Vitali R, Palone F, Armuzzi A, Fulci V, Negroni A, Carissimi C, Cucchiara S, Stronati L. Journal of Crohn's and Colitis. 2023 Jan 27;17(1):92-102. doi: 10.1093/ecco-jcc/jjac110. PMID: 36040453.

The post Proteomic Analysis Identifies Three Reliable Biomarkers of Intestinal Inflammation in the Stools of Patients With Inflammatory Bowel Disease appeared first on BioAegis Therapeutics.

]]> Blood-Borne Microparticles are an Inflammatory Stimulus in Type 2 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/36645851/#new_tab?utm_source=rss&utm_medium=rss&utm_campaign=blood-borne-microparticles-are-an-inflammatory-stimulus-in-type-2-diabetes-mellitus Sun, 01 Jan 2023 14:40:00 +0000 https://www.bioaegistherapeutics.com/?p=5817 Thom, SR, et al. ImmunoHorizons, 1 Jan 2023

The post Blood-Borne Microparticles are an Inflammatory Stimulus in Type 2 Diabetes Mellitus appeared first on BioAegis Therapeutics.

]]> Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia https://academic.oup.com/ofid/article/9/8/ofac357/6649582#new_tab?utm_source=rss&utm_medium=rss&utm_campaign=adjunctive-recombinant-human-plasma-gelsolin-for-severe-coronavirus-disease-2019-pneumonia Mon, 25 Jul 2022 14:42:00 +0000 https://www.bioaegistherapeutics.com/?p=5819 DiNubile, Mark J, et al. Open Forum Infectious Dieases, 25 July 2022.

The post Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia appeared first on BioAegis Therapeutics.

]]> Gelsolin as a Potential Biomarker for Endoscopic Activity and Mucosal Healing in Ulcerative Colitis https://www.mdpi.com/2227-9059/10/4/872#new_tab?utm_source=rss&utm_medium=rss&utm_campaign=gelsolin-as-a-potential-biomarker-for-endoscopic-activity-and-mucosal-healing-in-ulcerative-colitis Sat, 09 Apr 2022 16:18:00 +0000 https://www.bioaegistherapeutics.com/?p=5880 Maeda K, Nakamura M, Yamamura T, Sawada T, Ishikawa E, Oishi A, Ikegami S, Kakushima N, Furukawa K, Iida T, Mizutani Y, Ishikawa T, Ohno E, Honda T, Ishigami M, Kawashima H. Biomedicines. 2022 Apr 9;10(4):872. doi: 10.3390/biomedicines10040872. PMID: 35453622; PMCID: PMC9029534.

The post Gelsolin as a Potential Biomarker for Endoscopic Activity and Mucosal Healing in Ulcerative Colitis appeared first on BioAegis Therapeutics.

]]> Quorum Sensing by Gelsolin Regulates Programmed Cell Death 4 Expression and a Density-Dependent Phenotype in Macrophages https://pubmed.ncbi.nlm.nih.gov/34362832/#new_tab?utm_source=rss&utm_medium=rss&utm_campaign=quorum-sensing-by-gelsolin-regulates-programmed-cell-death-4-expression-and-a-density-dependent-phenotype-in-macrophages Fri, 06 Aug 2021 18:39:00 +0000 https://www.bioaegistherapeutics.com/?p=3365 Reshma Kumari Sharma, et al. Journal of Immunology, 06 August 2021.

The post Quorum Sensing by Gelsolin Regulates Programmed Cell Death 4 Expression and a Density-Dependent Phenotype in Macrophages appeared first on BioAegis Therapeutics.

]]> Plasma Gelsolin Modulates the Production and Fate of IL-1β-Containing Microparticles Following High-Pressure Exposure and Decompression https://journals.physiology.org/doi/abs/10.1152/japplphysiol.01062.2020#new_tab?utm_source=rss&utm_medium=rss&utm_campaign=plasma-gelsolin-modulates-the-production-and-fate-of-il-1%25ce%25b2-containing-microparticles-following-high-pressure-exposure-and-decompression Thu, 25 Mar 2021 14:45:00 +0000 https://www.bioaegistherapeutics.com/?p=5821 Bhopale, Veena M., et al. Journal of Applied Physiology, 25 March 2021.

The post Plasma Gelsolin Modulates the Production and Fate of IL-1β-Containing Microparticles Following High-Pressure Exposure and Decompression appeared first on BioAegis Therapeutics.

]]>